Transcriptional Regulation of the Murine Urokinase-type Plasminogen Activator Gene in Skeletal Myoblasts

Summary

We have previously shown that urokinase-type plasminogen activator (uPA) is highly expressed in murine C2C12 myoblasts and that antibodies against uPA are able to block both myoblast fusion and differentiation. Here we show the characterization of cis-acting elements in the mouse uPA promoter in vitro which are involved in uPA gene expression in C2C12 myoblast cells. DNase I hypersensitive (HS) site analysis revealed the presence of three HS sites in myoblasts. Deletion analysis of stably transfected uPA-promoter constructs revealed that at least two of the three HS sites accounted for the high transcriptional expression in C2C12 cells. One was located at -2.4 kb and corresponded to a known PEA3/AP1_A element and the other one was located at -4.9 kb and contained a CArG box and a CRE element. So far, no regulatory function had been assigned to this CRE/CArG element. Both HS sites alone were able to activate transcription of a heterologous promoter and showed a cooperative effect when placed together. Electrophoretic mobility-shift assays using myoblast nuclear extracts and specific antibodies demonstrated that cJun, JunD and ATF2 bound to the PEA3/AP1_A element, whereas the CRE/CArG element bound SRF. Altogether, these results suggest that high uPA expression in myoblasts is dependent on the cooperation of two regulatory sites in the uPA promoter.

• References

• 1 Danø K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer.. Adv Cancer Res 1985; 44: 139-265.
• 2 Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis.. Blood 1991; 78: 3114-24.
• 3 Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system.. J Clin Invest 1991; 88: 1067-72.
• 4 Carmeliet P, Collen D. Targeted gene manipulation and transfer of the plasminogen and coagulation systems in mice.. Fibrinolysis 1996; 10: 195-213.
• 5 Carlson BM, Faulkner JA. The regeneration of skeletal muscle fibers following injury: a review.. Med Sci Sports Exercise 1983; 15: 187
• 6 Yagami-Hiromasa T, Sato T, Kurisaki T, Kamijo K, Nabeshima Y-I, Fujisawa-Sehara A. A metalloprotease-disintegrin participating in myoblast fusion.. Nature 1995; 377: 652-6.
• 7 Gogos JA, Thompson R, Lowry W, Sloane BF, Weintraub H, Horwitz M. Gene trapping in differentiating cells lines: Regulation of the lysosomal protease cathepsin B in skeletal myoblast growth and fusion.. J Cell Biol 1996; 134: 837-47.
• 8 Couch CB, Strittmatter WJ. Rat myoblast fusion requires metalloendopro-tease activity.. Cell 1983; 32: 257-65.
• 9 Guerin CW, Holland PC. Synthesis and secretion of matrix-degrading metalloproteases by human skeletal muscle satellite cells.. Developm Dynam 1995; 202: 91-9.
• 10 Hantai D, Soria C, Soria J, Blondet B, Barlovatz-Meimon G, Rao JS, Festoff BW. Plasminogen activators in development, injury and pathology of the neuromuscular system. In Serine proteases and their inhibitors in the nervous system.. Festoff BW. ed Plenum Press; New York: 1991: 219-28.
• 11 Barlovatz-Meimon G, Frisdal E, Bassaglia Y, Hantai D, Angles-Cano E, Gautron J. Relationship between plasminogen activators and regeneration capacities of rat skeletal muscles. In Serine proteases and their serpin inhibitors in the nervous system.. Festoff BW. ed Plenum Press; New York: 1990: 229-41.
• 12 Muñoz-Canoves P, Miralles F, Baiget M, Felez J. Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro.. Thromb Haemost 1997; 77: 526-34.
• 13 Miralles F, Ron D, Baiget M, Felez J, Muñoz-Canoves P. Differential regulation of urokinase-type plasminogen activator expression by basic fibroblast growth factor and serum in myogenesis. Requirement of a common mitogen-activated protein kinase pathway.. J Biol Chem 1998; 273: 2052-8.
• 14 Festoff BW, Patterson MR, Romstedt K. Plasminogen activator: The major secreted neutral protease of cultured skeletal muscle cells.. J Cell Physiol 1982; 110: 190-5.
• 15 Wells J, Strickland S. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.. J Cell Physiol 1997; 171 (02) 217-25.
• 16 Horrevoets AJG, Smilde A, de Vries C, Pannekoek H. The specific roles of finger and kringle 2 domains of tissue- type plasminogen activator during in vitro fibrinolysis.. J Biol Chem 1994; 269: 12639-44.
• 17 Verde P, Boast S, Franze A, Robbiati F, Blasi F. An upstream enhancer and a negative element in the 5’ flanking region of the human urokinase plasminogen activator gene.. Nucleic Acids Res 1988; 16: 10699-716.
• 18 Hansen SK, Nerlov C, Zabel U, Verde P, Johnsen M, Baeuerle PA, Blasi F. A novel complex between the p65 subunit of NF-kappaB and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene.. EMBO J 1992; 11: 205-13.
• 19 Novak U, Cocks BG, Hamilton JA. A labile repressor acts through the NFkB-like binding sites of the human urokinase gene.. Nucleic Acids Res 1991; 19: 3389-93.
• 20 Lee JS, Catanziriti L, Hemmings BA, Kiefer B, Nagamine Y. Activation of cAMP-dependent protein kinase alters the chromatin structure of the urokinase-type plasminogen activator gene promoter.. Nucleic Acids Res 1994; 22: 569-75.
• 21 Soubt MK, Marksitzer R, Menoud P-A, Nagamine Y. Role of tissue-specific transcription factor LFB3 in a cyclic AMP-responsive enhancer of the urokinase-type plasminogen activator gene in LLC-PK1 cells.. Mol Cell Biol 1998; 18: 4698-706.
• 22 Besser D, Verde P, Nagamine Y, Blasi F. Signal transduction and the uPA/uPAR system.. Fibrinolysis 1996; 10: 215-37.
• 23 Miralles F, Parra M, Caelles C, Nagamine Y, Felez J, Muñoz-Canoves P. UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: requirement of an AP1 enhancer element.. Mol Cell Biol 1998; 18: 4537-47.
• 24 Besser D, Presta M, Nagamine Y. Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH3T3 fibroblasts.. Cell Growth Differ 1995; 6: 1009-17.
• 25 Kawamoto L, Makino K, Orita S, Nakata A, Kakunaga T. DNA bending and binding factors of the human α-actin promoter.. Nucleic Acids Res 1989; 17: 523-37.
• 26 Cassady AI, Stacey KJ, Nimmo KA, Murphy KM, Von der Ahe D, Pearson D, Botteri FM, Nagamine Y, Hume DA. Constitutive expression of the urokinase plasminogen activator gene in murine Raw264 macrophages involves distal and 5’ non-coding sequences that are conserved between mouse and pig.. Nucleic Acids Res 1991; 19: 6839-47.
• 27 Nerlov C, Rorth P, Blasi F, Johnsen M. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity.. Oncogene 1991; 6: 1583-92.
• 28 Nerlov C, De Cesare D, Pergola F, Caracciolo A, Blasi F, Johnsen M, Verde P. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells.. EMBO J 1992; 11: 4573-82.
• 29 D’Orazio D, Besser D, Marksitzer R, Kunz C, Hume DA, Kiefer B, Nagamine Y. Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2.. Gene 1997; 201: 179-87.
• 30 van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, Angel P. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents.. EMBO J 1995; 14: 1798-811.
• 31 Devary Y, Gottlieb RA, Lau LF, Karin M. Rapid and preferential activation of the c-jun gene during the mammalian UV response.. Mol Cell Biol 1991; 11: 2804-11.
• 32 Boxer LM, Prywes R, Roeder RG, Kedes L. The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factor.. Mol Cell Biol 1989; 9: 515-22.
• 33 Soulez M, Tuil D, Kahn A, Gilgenkrantz H. The serum response factor (SRF) is needed for muscle-specific activation of CArG boxes.. Biochem Biophys Res Commun 1996; 219: 418-22.
• 34 Arias J, Alberts AS, Brindle P, Claret FX, Smeal T, Karin M, Feramisco J, Montminy M. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor.. Nature 1994; 370: 226-9.
• 35 Rorth P, Nerlov C, Blasi F, Johnsen M. Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester.. Nucleic Acids Res 1990; 18: 5009-17.
• 36 Lee JS, Von der Ahe D, Kiefer B, Nagamine Y. Cytoskeletal reorganization and TPA differently modify AP-1 to induce the urokinase-type plasminogen activator gene in LLC-PK1 cells.. Nucleic Acids Res 1993; 21: 3365-72.
• 37 Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P, Karin M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.. Cell 1987; 49: 729-39.
• 38 Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.. Biochim Biophys Acta 1991; 1072: 129-57.
• 39 Hai T, Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.. Proc Natl Acad Sci USA 1991; 88: 3720-4.
• 40 De Cesare D, Vallone D, Caracciolo A, Sassone-Corsi P, Nerlov C, Verde P. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.. Oncogene 1995; 11: 365-76.
• 41 Chakraborty M, Chatterjee D, Gorelick FS, Baron R. Cell cycle-dependent and kinase-specific regulation of the apical Na/H exchanger and the Na,K-ATPase in the kidney cell line LLC-PK1 by calcitonin.. Proc Natl Acad Sci USA 1994; 91: 2115-9.
• 42 Menoud P-A, Matthies R, Hofsteenge J, Nagamine Y. Purification and cDNA cloning of a transcription factor which functionally cooperates within a cAMP regulatory unit in the porcine uPA gene.. Nucleic Acids Res 1993; 21: 1845-52.
• 43 Marksitzer R, Stief A, Menoud P-A, Nagamine Y. Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene.. J Biol Chem 1995; 270: 21833-8.
• 44 Montminy MR, Sevarino KA, Wagner JA, Mandel G, Goodman RH. Identification of a cyclic-AMP-responsive element within the rat soma-tostatin gene.. Proc Natl Acad Sci USA 1986; 83: 6682-6.
• 45 Kouzarides T, Ziff E. The role of the leucine zipper in the fos-jun interaction.. Nature 1988; 336: 646-51.
• 46 Papadopoulos N, Crow MT. Transcriptional control of the chicken cardiac myosin light-chain gene is mediated by two AT-rich cis-acting DNA elements and binding of serum response factor.. Mol Cell Biol 1993; 13: 6907-18.
• 47 Uetsuki T, Nabeshima Y, Fujisawa-Sehara A, Nabeshima Y-I.. Regulation of the chicken embryonic myosin light-chain (L23) gene: Existence of a common regulatory element shared by myosin alkali light-chain genes. Mol Cell Biol 1990; 10:: 2562-9.
• 48 Toutant M, Gauthier-Rouviere C, Fiszman MY, Lemonnier M. Promoter elements and transcriptional control of the chicken α tropomycin gene.. Nucleic Acids Res 1994; 22: 1838-45.
• 49 Treisman R.. A growth factor responsive transcriptional regulator.. Sem.Cancer Biol. 1990; 1:: 47-58.
• 50 Chow KL, Schwartz RJ. A combination of closely associated positive and negative cis-acting elements regulates transcription of the skeletal α-actin gene.. Mol Cell Biol 1990; 10: 528-38.
• 51 Catala F, Wanner R, Barton P, Cohen A, Wright W, Buckingham M. A skeletal muscle-specific enhancer regulated by factors binding to E and CArG boxes is present in the promoter of the mouse myosin light-chain 1A Gene.. Mol Cell Biol 1995; 15: 4585-96.
• 52 Vincent CK, Gualberto A, Patel CV, Walsh K. Different regulatory sequences control creatine kinase-M gene expression in directly injected skeletal and cardiac muscle.. Mol Cell Biol 1993; 13: 1264-72.